Conduit Pharmaceuticals (NASDAQ:CDT) Posts Earnings Results

Conduit Pharmaceuticals (NASDAQ:CDT) released its earnings results on Friday. The company reported ($20.33) earnings per share (EPS) for the quarter, Zacks reports.

Conduit Pharmaceuticals Stock Up 15.9 %

CDT traded up $0.12 during trading on Friday, reaching $0.89. The company had a trading volume of 5,269,309 shares, compared to its average volume of 1,017,237. Conduit Pharmaceuticals has a 52 week low of $0.73 and a 52 week high of $392.00. The business has a 50 day simple moving average of $2.03 and a 200-day simple moving average of $7.20.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.